Inhibitors of DNA Methylation - Archive ouverte HAL Accéder directement au contenu
Chapitre D'ouvrage Année : 2022

Inhibitors of DNA Methylation

Résumé

DNA methylation is involved in numerous biological processes and is deregulated in human diseases. The modulation of the activity of the enzymes and proteins in charge of DNA methylation, for example, DNA methyltransferases (DNMTs), can represent a powerful strategy to alter DNA methylation patterns and restore biological processes that are aberrant in diseases. In this chapter, we present examples of inhibitors of DNMTs (DNMTi). We review their fields of application either as therapeutic molecules, for example, in cancers, cardiovascular, neurological, and infectious diseases or as bioengineering tools. Finally, novel strategies to target DNA methylation and overcome the limits of single DNMT inhibitors will be described. These strategies consist in either targeting the methyl group reader proteins rather than targeting directly DNMTs or to combine within the same molecule a DNMT inhibitor with an additional active moiety, e.g., HDAC inhibitor, to improve efficacy and lower secondary effect of such drug.
Fichier principal
Vignette du fichier
Arimondo-Chap17_Ed2_V-HAL.pdf (1.3 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Licence : Copyright (Tous droits réservés)

Dates et versions

hal-04269122 , version 1 (03-11-2023)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Marie Lopez, Julie Gilbert, Jean Contreras, Ludovic Halby, Paola B Arimondo. Inhibitors of DNA Methylation. DNA Methyltransferases - Role and Function [Second Edition], 1389, pp.471-513, 2022, Advances in Experimental Medicine and Biology, 978-3-031-11454-0 (eBook). ⟨10.1007/978-3-031-11454-0_17⟩. ⟨hal-04269122⟩
83 Consultations
79 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More